IMPROVING UTILISATION OF PARENTERAL IRON THERAPY FOR TREATMENT OF IRON DEFICIENCY ANAEMIA IN MEDICAL WARDS OF HOSPITAL KUALA LUMPUR

Authors

  • Gan Shiau Shuang Author
  • Sharifah Suryani Syed Rahim Shah Author
  • Adelin Yong Sue Wen Author
  • Marilyn Tan May Yeen Author
  • Chang Cheok Ee Author
  • Lee Hooi Peng Author

DOI:

https://doi.org/10.63719/qbulletin.v1i33.306

Keywords:

Iron deficiency anaemia, Parenteral iron, Quality improvement study

Abstract

Parenteral iron, despite being the recommended treatment for iron deficiency anaemia (IDA) in hospitalised patients, was underutilised in medical wards of Hospital Kuala Lumpur (HKL), where excessive use of blood transfusions for treating IDA was observed. A verification study in 2020 showed only 9.3% of IDA patients in HKL received parenteral iron. The indicator used was the percentage of IDA patients who received parenteral iron. The standard is 40% based on haematologist consensus and as practiced in tertiary hospitals abroad. This quality improvement study was conducted using universal sampling in selected medical wards from September 2020 until July 2022 in two consecutive phases. All IDA patients with traceable records were included, giving a total of 182 subjects throughout the study. A survey was conducted among healthcare providers to identify contributing factors to the underutilisation. Main contributing factors include a lack of confidence in using parenteral iron (52.8%), cost concerns (20.2%), lack of trained staff for monitoring (15.7%), and no protocol to guide its use (15.7%). Parenteral Iron Infusion Protocol (PREFER) was developed. Several continuous medical and nursing education sessions were conducted for training and to introduce PREFER. More strategies included were building a website with the feature of a smart dose calculator, poster displays in the wards, and adding iron derisomaltose to the hospital formulary. Implementation led to an increase in parenteral iron utilisation from 9.3% to 33.3%, conserving 100 pints of blood and saving MYR 8000.00 monthly. We plan to expand the study to other disciplines and promote PREFER at the state and national levels.

Author Biographies

  • Gan Shiau Shuang

    Pharmacy Department, Hospital Kuala Lumpur, Ministry of Health Malaysia

  • Sharifah Suryani Syed Rahim Shah

    General Medicine Department, Hospital Kuala Lumpur, Ministry of Health Malaysia

  • Adelin Yong Sue Wen

    Pharmacy Department, Hospital Kuala Lumpur, Ministry of Health Malaysia

  • Marilyn Tan May Yeen

    Pharmacy Department, Hospital Kuala Lumpur, Ministry of Health Malaysia

  • Chang Cheok Ee

    Pharmacy Department, Hospital Kuala Lumpur, Ministry of Health Malaysia

  • Lee Hooi Peng

    Pharmacy Department, Hospital Kuala Lumpur, Ministry of Health Malaysia

References

1. Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet [Internet]. 2017 Sep 16;390(10100):1211–59. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673617321542

2. Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med [Internet]. 2020 Feb 12;287(2):153–70. Available from: https://onlinelibrary.wiley.com/doi/10.1111/joim.13004

3. Institute for Public Health (IPH). National Health and Morbidity Survey 2015 (NHMS 2015). Vol. II: Non-Communicable Diseases, Risk Factors & Other Health Problems. 2015.

4. Abdullah N, Ismail N, Abd Jalal N, Mohd Radin F, Othman R, Kamalul Arifin AS, et al. Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants. Ann Hematol [Internet]. 2020 Nov 25;99(11):2521–7. Available from: https://link.springer.com/10.1007/s00277-020-04279-w

5. Barragán-Ibañez G, Santoyo-Sánchez A, Collazo-Jaloma J, Ramos-Peñafiel CO. Retrospective analysis of therapeutic response obtained with enteral and parenteral iron in adults with iron deficiency anaemia. Revista Médica Del Hospital General De México [Internet]. 2015 Jul 1;78(3):112–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0185106315000487

6. Patel K, Memon Z, Mazurkiewicz R. Management of Iron-Deficiency Anemia on Inpatients and Appropriate Discharge and Follow-Up. J Hematol [Internet]. 2020 Apr 1;9(1–2):5–8. Available from: http://www.thejh.org/index.php/JH/article/view/626

7. Tan PP, Chang CT, Mohd Noor S. Blood supply management during the Covid-19 pandemic: Experience in a tertiary referral hospital in Malaysia. Transfusion and Apheresis Science [Internet]. 2021 Feb;60(1):102982. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1473050220303049

8. Spahn DR, Shander A, Hofmann A. The chiasm: Transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol [Internet]. 2013;27(1):37–42. Available from: https://www.sciencedirect.com/science/article/pii/S1521689613000190

9. Spradbrow J, Lin Y, Shelton D, Callum J. Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation. CJEM [Internet]. 2017 May 7;19(3):167–74. Available from: https://www.cambridge.org/core/product/identifier/S1481803516003882/type/journal_article

10. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia. J Gen Intern Med [Internet]. 1992 Mar 1;7(2):145–53. Available from: http://link.springer.com/10.1007/BF02598003

11. Auerbach M, DeLoughery TG. Causes and diagnosis of iron deficiency and iron deficiency anemia in adults. In: UpToDate. 2024.

12. Auerbach M, DeLoughery TG. Treatment of iron deficiency anemia in adults. In: Means RT, editor. UpToDate. Wolters Kluwer; 2024.

13. Bloor SR, Schutte R, Hobson AR. Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota. Microbiol Res (Pavia) [Internet]. 2021 Jun 12;12(2):491–502. Available from: https://www.mdpi.com/2036-7481/12/2/33

14. Gómez-Ramírez S, Brilli E, Tarantino G, Muñoz M. Sucrosomial® Iron: A New Generation Innovation for Improving Oral Iron Tolerability and Effectiveness in Iron Deficiency Anemia Treatment? Nutrients [Internet]. 2020 Jun 16;12(6):1784. Available from: https://www.mdpi.com/2072-6643/12/6/1784

15. Giordano G, Napolitano M, Di Battista V, Lucchesi A. Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study. Ann Hematol [Internet]. 2021 Sep 2;100(9):2173–9. Available from: https://link.springer.com/10.1007/s00277-020-04361-3

16. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ [Internet]. 2013 Aug 15;347:f4822. Available from: http://www.bmj.com/content/347/bmj.f4822.abstract

17. Willmann PA, Dean A. Retrospective Review of Total-Dose Iron Dextran in Iron-Deficiency Anemia of Chronic Disease and Relevance to Blood Transfusion Requirements: An Individual Institution Experience. Blood [Internet]. 2008;112(11):2876. Available from: https://www.sciencedirect.com/science/article/pii/S0006497119501689

18. Medscape. Red blood cells (Blood Component): Dosing & Uses [Internet]. [cited 2022 May 22]. Available from: https://reference.medscape.com/drug/rbcs-red-blood-cells-999507

19. Nurkhodrulnada Muhamad Lattepi. Intravenous Iron for Iron Deficiency Anemia (IDA). 2019.

20. Prescriber HKL Master Drug List. Pharmacy Department, Hospital Kuala Lumpur. 2020.

21. CosmoFer [package insert]. United Kingdom: Pharmacosmos UK Limited; 2020.

22. Monofer [package insert]. Denmark: Pharmacosmos A/S; 2021.

23. Venofer [package insert]. Germany: IDT Biologika GMBH; 2020.

24. Lim W, Afif W, Knowles S, Lim G, Lin Y, Mothersill C, et al. Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. Vox Sang [Internet]. 2019 May 2;114(4):363–73. Available from: https://onlinelibrary.wiley.com/doi/10.1111/vox.12773

25. Szebeni J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, et al. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol [Internet]. 2015 Nov 25;172(21):5025–36. Available from: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13268

26. Mahmoud Elrefaey N, Hassan Ali Awad W, Mohamed Abdelaziz T. Assessment of Nurses’ Safety Practices in relation to Intravenous Iron Administration for Patients Undergoing Hemodialysis. Egyptian Journal of Health Care [Internet]. 2021;12(2):1491–501. Available from: https://ejhc.journals.ekb.eg/article_191029_1cf8ee150c553d523bb1778762758e41.pdf

27. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol [Internet]. 2011 May 21;4(3):177–84. Available from: http://journals.sagepub.com/doi/10.1177/1756283X11398736

28. Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus [Internet]. 2014 Jul;12(3):296–300. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25074787

29. Mayson E, Ampt AJ, Shand AW, Ford JB. Intravenous iron: barriers and facilitators to its use at nine maternity hospitals in New South Wales, Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology [Internet]. 2016 Apr 5;56(2):162–72. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ajo.12417

30. Gewarges M, Sklar J, Wilkinson K, Gentilin A, McLean B, Hajjaj O, et al. PUMPING IRON: A QUALITY IMPROVEMENT STUDY FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN AMBULATORY HEART FAILURE PATIENTS. Canadian Journal of Cardiology [Internet]. 2022 Oct 1;38(10):S166. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0828282X22006547

31. Eboreime E, Banke-Thomas A, Obi-Jeff C, Adelabu Y, Balogun M, Aiyenigba AA, et al. A continuous quality improvement strategy to strengthen screening practices and facilitate the routine use of intravenous iron for treating anaemia in pregnant and postpartum women in Nigeria: a study protocol. Implement Sci Commun [Internet]. 2023 Mar 7;4(1):22. Available from: https://implementationsciencecomms.biomedcentral.com/articles/10.1186/s43058-023-00400-y

32. Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica [Internet]. 2014 Nov 1;99(11):1671–6. Available from: http://www.haematologica.org/cgi/doi/10.3324/haematol.2014.111492

Downloads

Published

31-10-2024

Issue

Section

Articles

How to Cite

1.
IMPROVING UTILISATION OF PARENTERAL IRON THERAPY FOR TREATMENT OF IRON DEFICIENCY ANAEMIA IN MEDICAL WARDS OF HOSPITAL KUALA LUMPUR. Q Bulletin [Internet]. 2024 Oct. 31 [cited 2026 Nov. 23];1(33). Available from: https://journal.nih.gov.my/index.php/qbulletin/article/view/306

Similar Articles

21-30 of 40

You may also start an advanced similarity search for this article.